AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06451341 — intervention group
Intervention type: BEHAVIORAL
Intervention: Needs and Barriers Assessment
Description: The Needs and Barriers Assessment is a questionnaire designed to assess patient participant barriers and social determinants of health, emotional challenges related to antiretroviral therapy, and the impact of switching to CAB+RPV LA treatment.~This will be administered at Baseline, Month 7 and Month 15.
Study NCT06451341 — intervention group
Intervention type: BEHAVIORAL
Intervention: Pre-visit Outreach
Description: Patient participants will be contacted prior to each clinical injection visit for an appointment reminder and a needs assessment.
Study NCT06451341 — intervention group
Intervention type: BEHAVIORAL
Intervention: Qualitative interview
Description: Qualitative interviews will be conducted within thirty days after study completion at Month 15 to further evaluate the participant's experience with the implementation of CAB+RPV LA treatment.
Study NCT06451341 — intervention group
Intervention type: BEHAVIORAL
Intervention: Staff education
Description: Staff participants will participate in Extension for Community Healthcare Outcomes (Project ECHO) educational sessions with topics such as fundamentals of HIV treatment and care, HIV outcomes, delivery of antiretroviral therapies (ART) including long-acting ART, cultural sensitivity, and social determinants of health in rural areas.
Study NCT06370741 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Stretching with/without device
Description: Participants will be divided into two groups: Achilles tendon stretching and plantar fascia specific stretching. Within these two groups, participants will stretch their dominant side with the help of the designed tool. On the non-dominant side, the Achilles tendon group will complete the Achilles tendon stretching without a tool and the plantar fascia-specific stretching group will complete the self plantar fascia stretching exercise. Each stretching exercise will be performed for 10 seconds and 10 repetitions 3 days a week for 2 weeks.
Study NCT06370741 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Stretching with/without device
Description: Participants will be divided into two groups: Achilles tendon stretching and plantar fascia specific stretching. Within these two groups, participants will stretch their dominant side with the help of the designed tool. On the non-dominant side, the Achilles tendon group will complete the Achilles tendon stretching without a tool and the plantar fascia-specific stretching group will complete the self plantar fascia stretching exercise. Each stretching exercise will be performed for 10 seconds and 10 repetitions 3 days a week for 2 weeks.
Study NCT06499532 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Monitoring and Surgical removal of mandibular impacted wisdom teeth, using Gow-Gates anesthesia technique
Description: The surgical removal of impacted mandibular wisdom teeth in patients included in the study arms was performed using Gow-Gates anesthesia technique. Patients were monitored for TCR during the procedure.
Study NCT06499532 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Monitoring and Surgical removal of mandibular impacted wisdom teeth, using inferior alveolar nerve block anesthesia technique
Description: The surgical removal of impacted mandibular wisdom teeth in patients included in the study arms was performed using inferior alveolar nerve block anesthesia technique and supplemental anesthesia (buccal- mylohyoid). Patients were monitored for TCR during the procedure.
Study NCT05701176 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: [18F]F-AraG PET scan
Description: \[18F\]F-AraG PET scans are performed to assess the accumulation of activated T-cells in the tumour and healthy tissue.
Study NCT05795192 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Taking Placebo orally once a day
Study NCT05555199 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 99mTc-nanocolloid
Description: Injection of 99mTc-nanocolloid when lung cancer is diagnosed during a navigation bronchoscopy, followed by one or two SPECT/CT-scans.
Study NCT05381740 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Novel rTMS Approach
Description: Participants in this arm will receive rTMS-based facilitation of the contralesional higher motor cortices located in the non-stroke hemisphere before the start of each rehabilitation session. High-frequency rTMS (5Hz) will be delivered using 42 10 second trains of 50 pulses each (total 2100 pulses) for a period of 22 minutes. Immediately after the completion of rTMS, participants will undergo therapist-guided upper limb therapy for a total of one hour. Participants will receive these interventions 2 days a week for 6 weeks for a total of 12 sessions.
Study NCT05381740 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS Approach
Description: Participants in this arm will receive sham rTMS given over the contralesional higher motor cortices located in the non-stroke hemisphere before the start of each rehabilitation session. Immediately after the completion of sham rTMS, participants will undergo therapist-guided upper limb therapy for a total of one hour. Participants will receive these interventions 2 days a week for 6 weeks for a total of 12 sessions.
Study NCT05555199 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ICG
Description: If patient undergoes surgery to treat the lung cancer, ICG will be injected and retrieved fluorescent lymph nodes will undergo additional pathological assessment.
Study NCT05542004 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral Economic Principles
Description: The control arm will receive no letter to reflect the background vaccination uptake. Intervention arms will test the effects of different letters developed using behavioral economic principles.
Study NCT05296785 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: intramedullary nail with Limb Reconstruction System
Description: bone transport by Limb Reconstruction System over intramedullary nail on fracture tibia
Study NCT05223855 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapeutic hydrotherapy treatment
Description: Physiotherapeutic hydrotherapy treatment The intervention consists of physiotherapeutic one-on-one treatment in a 34-36 degrees centigrade hot water, where the participants are placed supine in the water supported by the physiotherapist as well as buoyant aqua noodles. The physiotherapist supports and moves the participants in the water and adapts to the participant's reaction.~The combination of heat, water, movement and touch affects the musculoskeletal and neuromuscular systems and thus has a depth-relaxing effect (Schoedinger, 2010).
Study NCT04721249 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: D-serine
Description: Patients will receive four 500mg capsules of D-serine each day over a course of six weeks (two after breakfast and two after dinner).
Study NCT04721249 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients in the placebo group will receive four placebo capsules each day (two after breakfast and two after dinner). The placebo capsules will contain Mannotol / Mannitol-Silica (99.5/0.5, respectively) and will be indistinguishable from D-serine by matching colour, shape, size and packaging.
Study NCT05272254 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 10% povidone iodine + FV
Description: applied to children's teeth
Study NCT05272254 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo +FV
Description: applied to children's teeth
Study NCT05763732 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rhythmic Auditory Stimulation (RAS)
Description: Rhythmic auditory stimulus (RAS) is a Neurologic Music Therapy (NMT) technique that utilizes an auditory rhythmic cue to entrain gait to a specific rhythm.~RAS, as an anticipatory time cue, can be used as both an immediate entrainment stimulus, providing rhythmic cues during movement, and as a facilitating stimulus for planning and executing a movement to achieve more functional gait patterns. Cadence, gait velocity, and stride length are the commonly used parameters to monitor changes in a patient's gait.
Study NCT04819204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cetrorelix Acetate
Description: GnRH antagonist - subcutaneous injection. Day 1: 1-3 mg; Days 2-14: 0.25mg/daily.
Study NCT04819204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Testosterone gel
Description: Testosterone gel - transdermal application of 5mg/day on Day 7-14 of GnRH antagonist
Study NCT00824759 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pure oxygen breathing versus air
Description: one group will breath pure oxygen; the other will breath air
Study NCT00824759 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: pure oxygen breathing versus air
Description: one group will breath pure oxygen; the other will breath air
Study NCT06410833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab weekly until B%\<0.5% or B#\<20×10\^6/L
Study NCT06410833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belimumab
Description: Belimumab every four weeks
Study NCT05392361 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: gabapentin (neurontin® capsule 300mg) treatment
Description: Taking gabapentin (neurontin® capsule 300mg, Pfizer) medication at night as a conservative treatment
Study NCT05392361 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: baclofen (baclofen Tab. 10mg) treatment
Description: Taking baclofen (baclofen Tab. 10mg, Handok co, Seoul, Korea) medication at night.
Study NCT05162495 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BioStation T101 and TeraTube
Description: Rapid detection of the novel SARS-CoV-2 (COVID-19) virus in breath samples.
Study NCT05652361 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Additional visualisation of surgical assistance during surgery
Description: Robot-assisted anterior rectal resection using daVinci® system as CE-marked gold standard with additional visualization of surgical assistance functions based on machine learning techniques
Study NCT05406882 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Live Combined Bifidobacterium and Lactobacillus Tablets、Compound Glutamine Entersoluble capsules
Description: Live Combined Bifidobacterium and Lactobacillus Tablets：probiotics. Compound Glutamine Entersoluble capsules：combined traditional Chinese medicine and glutamine
Study NCT05689424 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: HDV-Insulin Lispro
Description: The name of the investigational drug is Hepatic Directed Vesicles + Insulin Lispro (HDV-bound LIS). It is a nano-carrier-based formulation of insulin which is the active therapeutic ingredient in the product. The nano-carrier component of the formulation contains a hepatic target molecule, biotin phosphatidylethanolamine, which has an affinity for hepatocytes and enables the product to deliver insulin directly to the liver.
Study NCT05689424 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HDV-Insulin Lispro
Description: The name of the investigational drug is Hepatic Directed Vesicles + Insulin Lispro (HDV-bound LIS). It is a nano-carrier-based formulation of insulin which is the active therapeutic ingredient in the product. The nano-carrier component of the formulation contains a hepatic target molecule, biotin phosphatidylethanolamine, which has an affinity for hepatocytes and enables the product to deliver insulin directly to the liver.
Study NCT05352958 — intervention group
Intervention type: PROCEDURE
Intervention: Diaphragmatic ultrasound
Description: duration 15 minutes, performed at M0, M3, M6 and M9
Study NCT05352958 — intervention group
Intervention type: OTHER
Intervention: Electro-physiological exploration of the diaphragm
Description: duration between 30 and 60 minutes performed at M0
Study NCT06252831 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AS-Probionorm
Description: Dosage form - powder for the preparation of a solution for oral administration. Dosage regimen -1 sachet (1 g) take 2 times a day with an interval of 12 hours. Apply 15-20 minutes before meals in the morning and evening. Before use, the medicine is mixed with 30-50 ml of boiled water at room temperature, resulting in a cream-colored suspension. The resulting aqueous suspension should be drunk without achieving complete dissolution. The diluted drug cannot be stored. The duration of taking the medicine is 7 days. The study is carried out on an outpatient basis.~The total duration of each subject's participation in the clinical trial is no more than 21 ± 1 days. Throughout the entire study period, the research subject has the opportunity to contact the research team on all questions relating to the nature of this study. After completion of the entire observation period of 21 days, there is no follow-up of study subjects under the trial protocol.
Study NCT05217017 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: FACS
Description: Diagnostic Test: Assessment of disability and behavior (by questionnaires)
Study NCT05686668 — intervention group
Intervention type: OTHER
Intervention: assessment by scales
Description: Assessment from many scales: AASP, HARS, HDRS, CORE, EES, CISS, SHAPS at V1 Assessment from many scales: AASP, HARS, HDRS, CORE, EES, SHAPS at V2
Study NCT05768477 — intervention group
Intervention type: OTHER
Intervention: Consultation
Description: Consultation with the pain specialist, which might entail prescription of medication of vitamins.
Study NCT06585137 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Web-Based Mind-Body Awareness Program
Description: The program will be developed with the opinions of experts in line with the literature. It will include a nursing approach based on Meleis transition theory, education, mind-body awareness practices, and messages specific to the health of women. Participants will receive training consisting of 6 modules for an average of 2 weeks. Participants will be asked to complete the first post-test one day after the ovum pick-up (OPU) procedure, corresponding to an average of 8-12 days after ovulation induction. Afterward, pranayama breathing and autogenic relaxation exercises will be applied weekly via the interactive online system after the OPU procedure. Then, the second post-test will be applied in the 3rd month, and the third post-test will be applied in the 6th month.
Study NCT06386354 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Train-of-four
Description: Patients submitted to general anesthesia with neuromuscular block will be monitored at their arrival to the Post-Anesthesia Care Unit to assess the presence of residual neuromuscular block.
Study NCT06585163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrocodone Bitartrate
Description: Hydrocodone bitartrate oral suspension
Study NCT06585163 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Doxapram Hydrochloride
Description: Doxapram hydrocholoride oral suspension
Study NCT05768477 — intervention group
Intervention type: PROCEDURE
Intervention: Interventions
Description: Facet injections, nerve denervations, infiltrations, Qutenza, Spinal Cord Stimulation, Transcutaneous Electrical Nerve Stimulation
Study NCT05768477 — intervention group
Intervention type: DRUG
Intervention: Baxter therapy
Description: Ketamine or Linisol baxter therapy
Study NCT05223764 — intervention group
Intervention type: OTHER
Intervention: Follow up survey
Description: phone call follow-up to investigate women's decision not to return for embryo transfer after cancer treatment.
Study NCT05821998 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Thoracic block technique
Description: Manual compression of the healthy lung during expiration associated with the use of invasive or non invasive mechanical ventilation
Study NCT05821998 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Designed chest physical therapy program
Description: Percussion, vibration and modified postural drainage
Study NCT05768477 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interdisciplinary therapy
Description: Interdisciplinary therapy provided by the physiotherapist, psychologist and occupational therapist.
Study NCT05718232 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lenvatinib
Description: Lenvatinib will be taken within 3 days of randomization (dose: 8 mg qd for patients \<60kg, and 12 mg qd for patients ≥ 60kg)
Study NCT05718232 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenvatinib
Description: Lenvatinib will be taken within 3 days of randomization (dose: 8 mg qd for patients \<60kg, and 12 mg qd for patients ≥ 60kg)
Study NCT05718232 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: TACE
Description: TACE will be performed one day after oral administration of lenvatinib. Either cTACE or DEB-TACE can be used, depending on the condition of each center.
Study NCT05718232 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT
Description: SBRT will be given within 3 weeks after the first TACE with linear accelerator-based photon beams. Gross tumor volume is defined as intrahepatic tumor and vascular invasion including a 1-cm margin into the contiguous HCC. Prescription dose will be 4500-5000 cGy in 5-8 fractions.
Study NCT05169788 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Teen On-line Problem Solving
Description: The TOPS program is a web-based platform delivered on computers and tablets, which is composed of different self-guided, online sessions on different contents: executive functions, social skills, behavioral strategies, injury-related issues and health and wellness. The TOPS program has been designed to be performed by patients and their families at home. Biweekly Google Meet videoconferences between a coach with expertise in cognitive-behavioral psychotherapy and patients are scheduled along the entire duration of the program.
Study NCT05169788 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Teen On-line Problem Solving
Description: The TOPS program is a web-based platform delivered on computers and tablets, which is composed of different self-guided, online sessions on different contents: executive functions, social skills, behavioral strategies, injury-related issues and health and wellness. The TOPS program has been designed to be performed by patients and their families at home. Biweekly Google Meet videoconferences between a coach with expertise in cognitive-behavioral psychotherapy and patients are scheduled along the entire duration of the program.
Study NCT04693390 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Application of acupuncture
Study NCT05888285 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector spina plane block
Description: The transverse processes of the thoracic vertebrae are treated with ultrasound-guided drug injection
Study NCT05888285 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Erector spina bale block and pulsed radiofrequency
Description: The transverse processes of the thoracic vertebrae are treated with ultrasound-guided drug injection and pulsed radiofrequency treatment
Study NCT02871726 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TRUS-Robot
Description: A robotic device used to hold and manipulate the ultrasound probe during a transrectal prostate biopsy.
Study NCT02871726 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TRUS biopsy
Description: Uronav for prostate biopsy.
Study NCT02871726 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TRUS biopsy
Description: Uronav for prostate biopsy.
Study NCT05749562 — intervention group
Intervention type: DEVICE
Intervention: Cheneau-Toulouse-Munster brace
Description: Full length, orthogonal anteroposterior and lateral X-rays will be taken with the Cheneau-Toulouse-Munster brace.
Study NCT05619991 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group watching video
Description: The video will include preparation for the surgery, the operating room environment and the post-operative process.
Study NCT05619991 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Scheduled training group
Description: The scheduled training will include preparation for the surgery, the operating room environment and the post-operative process.
Study NCT05244954 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-Piperaquine
Description: Treatment of females less than 10 years old and all males in Arm 2 and those who test positive in Arm 1.
Study NCT05244954 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chloroquine
Description: Treatment of females 10 years old and older in Arm 2 and those who test positive in Arm 1.
Study NCT05830422 — intervention group
Intervention type: OTHER
Intervention: nothing
Description: Follow-up observation was conducted without any intervention in an outpatient setting.
Study NCT05396573 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: RQ3013
Description: A single dose of 30 μg/0.15 mL, a single dose of 60 μg/0.3 mL
Study NCT05396573 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Comirnaty
Description: A single dose of 30 μg/0.3 mL
Study NCT05410717 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Claudin6, GPC3, Mesothelin, or AXL targeting CAR-NK cells
Description: Engineering Claudin6, GPC3, Mesothelin, or AXL targeting CAR combined with/or without IL7/CCL19 and/or scfv against PD1/CTLA4/Lag3 secreting vector into NK cells, which are isolated from patients with advanced ovarian cancer or other cancers with expression of Claudin6, GPC3, Mesothelin, or AXL, and then transfusing them back the patients.~In some cases, the CAR-NK cells will be combined with CBD or NAD to enhance the therapeutic efficacy.